Can a New Jersey resident get peptides by telehealth?
N.J.S.A. 45:1-61 through 45:1-66 (P.L.2017, c.117) let a New Jersey-licensed health care provider establish a provider-patient relationship and treat through telemedicine, held to the in-person standard of care. Section 2(c) of P.L.2017, c.117 (N.J.S.A. 45:1-62) says telemedicine services shall be provided using interactive, real-time, two-way communication technologies. Asynchronous store-and-forward technology may be used to transmit images, diagnostics, data, and medical information, and real-time two-way audio without video may be combined with store-and-forward only if, after reviewing the patient's medical records, the provider determines the in-person standard of care can be met. For an initial encounter the provider must review the patient's medical history and records before contact. The Board of Medical Examiners' rule N.J.A.C. 13:35-6B.5 adds that physician telemedicine must include a video component unless that audio exception applies. Because both the statute and the rule require a real-time interaction, this record treats questionnaire-only asynchronous prescribing as not allowed. Schedule II prescribing by telemedicine requires an initial in-person exam and in-person visits every three months, but that rule does not apply to the non-controlled peptides in this database. [2] [3] [4] [8]
How does the New Jersey pharmacy board treat compounding?
| Board | New Jersey State Board of Pharmacy (Division of Consumer Affairs) |
|---|---|
| Eligible substances | Follows the federal 503A framework |
The Board of Pharmacy regulates pharmacy under the Pharmacy Practice Act of 2003 (N.J.S.A. 45:14-40 and following) and N.J.A.C. 13:39, including subchapter 11 on compounding sterile preparations. N.J.S.A. 45:14-73 requires any pharmacy located in another state that ships, mails, distributes, or delivers prescription legend drugs into New Jersey to register with the Board, submit its most recent home-state inspection report, and provide a toll-free line to a pharmacist with access to patient records; N.J.A.C. 13:39-4.20 implements the registration. Board rule N.J.A.C. 13:39-11.25 bars compounding a commercially available drug product unless the prescriber determines the change produces a significant difference for the patient. In its statement on semaglutide compounding (the version posted on the Board's site is dated November 6, 2023), the Board said that no salt form of semaglutide may be used in a compounded drug, and that a pharmacy using semaglutide base must ensure it is pharmaceutical grade, accompanied by a valid certificate of analysis, and sourced from an FDA-registered establishment. New Jersey has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [5] [6] [7] [9] [11]
Can you get compounded GLP-1s in New Jersey?
Compounded semaglutide and tirzepatide are limited to the federal exception for documented patient specific needs because the FDA shortage allowances ended in 2025, and the Board's 2023 statement independently bars semaglutide salt forms and requires documented, FDA-registered sourcing of semaglutide base. [9] [14]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in New Jersey?
Verified access options
Prescriber licensed in New Jersey, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in New Jersey. Expect a live video or phone visit; questionnaire-only prescribing is not permitted.
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
Access paths are verified against public regulatory records and prescriber licensing. We never list unlicensed vendors.
Find a provider in New Jersey
Is it legal to buy research peptides in New Jersey?
New Jersey's food and drug law (N.J.S.A. Title 24) prohibits selling adulterated or misbranded drugs, and the Pharmacy Practice Act limits dispensing to licensed pharmacies. The Board's semaglutide statement also warns pharmacies against non-pharmaceutical-grade ingredients. [9] [10] [15]
Peptide-specific notes for New Jersey
| Peptide | Note |
|---|---|
| Semaglutide | Available branded by prescription, including by telemedicine under N.J.S.A. 45:1-61 and following. Compounded semaglutide is limited to the federal patient specific exception since April 22, 2025, and the New Jersey Board of Pharmacy bars any salt form of semaglutide in compounding. [9] [14] |
| BPC-157 | Not FDA approved and not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk; a state board cannot authorize what federal law does not. New Jersey pharmacies apply the federal eligibility test and the Board's sourcing expectations for pharmaceutical-grade ingredients. [9] [12] [13] |
Frequently asked questions
Can I get a GLP-1 prescription in New Jersey through telemedicine?
Yes, from a New Jersey-licensed provider. The Telemedicine and Telehealth Act lets providers establish a relationship and prescribe through telemedicine under the in-person standard of care, and semaglutide and tirzepatide are not controlled substances. [2] [3]
Does New Jersey allow asynchronous or store-and-forward telemedicine?
Only as part of a real-time visit. N.J.S.A. 45:1-62 requires telemedicine to use interactive, real-time, two-way communication; store-and-forward may be used to send images, data, and records, and may be paired with real-time audio when the provider finds the in-person standard of care can be met. The Board of Medical Examiners' rule requires video for physician telemedicine unless that audio exception applies, so a questionnaire-only visit does not meet New Jersey's requirements. [3] [4] [8]
What did the New Jersey Board of Pharmacy say about compounded semaglutide?
In a 2023 statement (the version on the Board's site is dated November 6, 2023) the Board said that no salt form of semaglutide may be used in compounding, and that semaglutide base must be pharmaceutical grade, carry a valid certificate of analysis, and come from an FDA-registered establishment. [9]
Is compounded semaglutide or tirzepatide still available in New Jersey?
Only in limited, patient specific cases. The federal shortage allowances ended in 2025, and New Jersey also bars semaglutide salt forms, so routine compounded GLP-1 programs are not lawful. [9] [14]
Can a New Jersey pharmacy compound BPC-157?
No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [11] [12] [13]
From the blog
- Can you get a GLP-1 through telehealth in your state?
Yes in every state, but the rules for the visit, the prescriber's license, and the pharmacy differ. How state telehealth law shapes GLP-1 access, with ten state examples.
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.
- [1]New Jersey State Board of Pharmacy (Division of Consumer Affairs)
- [2]N.J.S.A. 45:1-61, Definitions relative to telemedicine and telehealth
- [3]N.J.S.A. 45:1-62, Provision of health care through telemedicine or telehealth; requirements
- [4]New Jersey P.L.2017, c.117 (S291), Telemedicine and Telehealth Act
- [5]New Jersey Pharmacy Practice Act, N.J.S.A. 45:14-40 and following, and N.J.A.C. 13:39 (Board laws and regulations)
- [6]N.J.S.A. 45:14-73, Registration of out-of-State pharmacies; requirements
- [7]N.J.A.C. 13:39-4.20, Out-of-State pharmacy registration
- [8]N.J.A.C. 13:35-6B.5, Provision of health care services through telemedicine or telehealth (Board of Medical Examiners)
- [9]New Jersey State Board of Pharmacy: Statement concerning semaglutide compounding (posted version dated November 6, 2023)
- [10]N.J.S.A. Title 24, Food and drugs
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, September 22). Are peptides legal in New Jersey?. https://peptideagent.ai/legal/new-jersey- HTML link
<a href="https://peptideagent.ai/legal/new-jersey">Are peptides legal in New Jersey?</a>, PeptideAgent, updated September 22, 2026.